Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects

Acta Radiologica

Volumn 48, Issue 4, 2007, Pages 362-368

  Dahlstrom N ^a   Persson, A ^b   Albiin, N ^b   Smedby, O ^b   Brismar, T B ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Bile ducts; Biliary; Comparative studies; Intravenous contrast agents; Liver; MR imaging

Indexed keywords

GADOLINIUM COMPOUNDS; HEALTH CARE; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT;

BILE DUCTS; BILIARY; INTRAVENOUS CONTRAST AGENTS;

ANGIOGRAPHY;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; GADOLINIUM; GADOLINIUM ETHOXYBENZYL DTPA; GADOLINIUM PENTETATE; MEGLUMINE; ORGANOMETALLIC COMPOUND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BILE DUCT; COMPARATIVE STUDY; FEMALE; HEPATIC DUCT; HISTOLOGY; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; INTRAHEPATIC BILE DUCT; INTRAVENOUS DRUG ADMINISTRATION; LIVER; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; TIME;

ADULT; BILE DUCTS; BILE DUCTS, INTRAHEPATIC; CONTRAST MEDIA; FEMALE; GADOLINIUM; GADOLINIUM DTPA; HEPATIC DUCT, COMMON; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TIME FACTORS;

EID: 34247366377     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850701196922     Document Type: Article

References (25)

1. Becker CD, Grossholz M, Mentha G, de Peyer R, Terrier F. MR cholangiopancreatography: technique, potential indications, and diagnostic features of benign, postoperative, and malignant conditions. Eur Radiol 1997;7:865-74.
2. Bollow M, Taupitz M, Hamm B, Staks T, Wolf KJ, Weinmann HJ. Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation. Eur Radiol 1997;7:126-32.
3. Carlos RC, Branam JD, Dong Q, Hussain HK, Francis IR. Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient? Acad Radiol 2002;9:1322-5.
4. Carlos RC, Hussain HK, Song JH, Francis IR. Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment. Am J Roentgenol 2002;179:87-92.
5. Coakley FV, Schwartz LH. Magnetic resonance cholangiopancreatography. J Magn Reson Imaging 1999;9:157-62.
6. Cohen S, Bacon BR, Berlin JA, Fleischer D, Hecht GA, Loehrer PJ Sr, et al. National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002. Gastrointest Endosc 2002;56:803-9.
7. Hamm B, Staks T, Muhler A, Bollow M, Taupitz M, Frenzel T, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995;195:785-92.
8. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004;230:266-75.
9. Jonas E, Hultcrantz R, Slezak P, Blomqvist L, Schnell PO, Jacobsson H. Dynamic 99Tcm-HIDA SPET: non-invasive measuring of intrahepatic bile flow. Description of the method and a study in primary sclerosing cholangitis. Nucl Med Commun 2001;22:127-34.
10. Kim TK, Kim BS, Kim JH, Ha HK, Kim PN, Kim AY, et al. Diagnosis of intrahepatic stones: superiority of MR cholangiopancreatography over endoscopic retrograde cholangiopancreatography. Am J Roentgenol 2002;179:429-34.
11. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998;33:798-809.
12. Lim JS, Kim MJ, Jung YY, Kim KW. Gadobenate dimeglumine as an intrabiliary contrast agent: comparison with mangafodipir trisodium with respect to non-dilated biliary tree depiction. Korean J Radiol 2005;6:229-34.
13. Persson A, Dahlstrom N, Smedby O, Brismar TB. Volume rendering of three-dimensional drip infusion CT cholangiography in patients with suspected obstructive biliary disease: a retrospective study. Br J Radiol 2005;78:1078-85.
14. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging - a multicenter phase III clinical study. Radiology 2000;215:727-36.
15. Pirovano G, Vanzulli A, Marti-Bonmati L, Grazioli L, Manfredi R, Greco A, et al. Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions. Am J Roentgenol 2000;175:1111-20.
16. Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 2004;14:559-78.
17. Ryeom HK, Kim SH, Kim JY, Kim HJ, Lee JM, Chang YM, et al. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Korean J Radiol 2004;5:231-9.
18. Schuhmann-Giampieri G, Mahler M, Roll G, Maibauer R, Schmitz S. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans. J Clin Pharmacol 1997;37:587-96.
19. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992;183:59-64.
20. Wallner BK, Schumacher KA, Weidenmaier W, Friedrich JM. Dilated biliary tract: evaluation with MR cholangiography with a T2-weighted contrast-enhanced fast sequence. Radiology 1991;181:805-8.
21. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002;56:652-6.
22. Varghese JC, Farrell MA, Courtney G, Osborne H, Murray FE, Lee MJ. A prospective comparison of magnetic resonance cholangiopancreatography with endoscopie retrograde cholangiopancreatography in the evaluation of patients with suspected biliary tract disease. Clin Radiol 1999;54:513-20.
23. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, Vogler H, Frenzel T, Gries H. A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 1991;22:233-7; discussion 242.
24. Vittadini G, Felder E, Tirone P, Lorusso V. B-19036, a potential new hepatobiliary contrast agent for MR proton imaging. Invest Radiol 1988;23 Suppl 1:S246-8.
25. Zandrino F, Curone P, Benzi L, Ferretti ML, Musante F. MR versus multislice CT cholangiography in evaluating patients with obstruction of the biliary tract. Abdom Imaging 2005;30:77-85.